Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared For 2022” based on highlights it presented at the TGaS Advisors’ 2021 Fall Virtual Summit. The TGaS 2021 Fall Virtual Summit was held in November with over 450 attendees, the largest Summit to date.

As the commercial model continues to evolve, companies are capitalizing on opportunities to expand and enhance their capabilities. According to the new brief, the new normal is an array of hybrid/virtual/live engagements. Among the impacts are virtual speaker training, virtual/hybrid learning & development, virtual meetings & events and flexible HCP engagements. The mix of marketing channels and media is as crucial as the content being created. Website and mobile engagement, social media and personalized content, in addition to the sales team as a channel, are all critically important.

“The pandemic has driven an unprecedented transformation to the Pharma commercial model, and much uncertainty remains as we move into 2022. Achieving an optimal balance of client-facing resources and digital/virtual client engagement will be a critical priority while organizations continue to evolve their digital capabilities and advanced analytics,” said Gary McWalters, President of Client Solutions at Trinity Life Sciences. “TGaS Advisors remains engaged with our clients every step of the way as together we successfully tackle the opportunities and challenges ahead.”

To download the brief, please visit TrinityLifeSciences.com or click here.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005164/en/